|1.||Wang, Xuemei: 27 articles (11/2015 - 08/2006)|
|2.||Chen, Baoan: 22 articles (01/2012 - 08/2006)|
|3.||Cheng, Jian: 15 articles (08/2015 - 01/2008)|
|4.||Gao, Feng: 13 articles (02/2011 - 04/2006)|
|5.||Jiang, Hui: 11 articles (11/2015 - 06/2002)|
|6.||Gao, Chong: 10 articles (08/2015 - 01/2008)|
|7.||Orbán, Erika: 9 articles (05/2015 - 01/2009)|
|8.||Manea, Marilena: 9 articles (05/2015 - 04/2009)|
|9.||Wang, Jun: 9 articles (01/2012 - 01/2008)|
|10.||Guo, Dadong: 8 articles (03/2012 - 03/2008)|
|1.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/01/2000 - "De novo ANLL at diagnosis that achieved complete remission (CR) were significantly more sensitive to daunorubicin compared to those who didn't achieve CR (P<0.05). "
02/10/2013 - "Improved outcome in pediatric relapsed acute myeloid leukemia: results of a randomized trial on liposomal daunorubicin by the International BFM Study Group."
03/01/1988 - "While the efficacy of daunorubicin (DNR) in first induction of patients with acute nonlymphoblastic leukemia (ANLL) has been well documented, little data are available concerning the activity of DNR in patients with relapsed and refractory ANLL previously treated with anthracycline. "
01/01/2015 - "High Doses of Daunorubicin during Induction Therapy of Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Clinical Trials."
01/01/2013 - "A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor."
01/01/1979 - "The therapeutic efficacy of both complexes was significantly better than that of free daunorubicin in the sensitive tumor. "
02/11/1968 - "[Efficacy of a new antineoplastic antibiotic, daunomycin, in the therapy of malignant tumors in children]."
11/01/2002 - "The in vivo studies suggested a prolonged release of 20 hr. Niosomal daunorubicin hydrochloride exhibited an enhanced anti-tumor efficacy when compared to free drug. "
06/05/2015 - "Thus, inhibition of CBR1 may increase the efficacy of daunorubicin in cancer tissue and simultaneously decrease its cardiotoxicity. "
10/01/2008 - "The efficacy of daunorubicin depends on the intracellular amount in the tumor cell. "
01/01/1978 - "Daunomycin: an anthracycline antibiotic effective in acute leukemia."
04/01/2015 - "We report the outcome of 141 patients (median age 51 years; range, 19-82, 31 % ≥60 years) enrolled into the prospective Study Alliance Leukemia (SAL)-AIDA2000 trial, which comprised AIDA-based induction followed by only two courses of risk-adapted consolidation (daunorubicin or mitoxantrone ± cytarabine) followed by 2-year maintenance treatment. "
10/01/2014 - "[Therapeutic study of leukemia by pegylated liposomal daunorubicin]."
05/01/2014 - "The present study investigated the effect of miR-125b on the resistance of leukemia cell lines to the chemotherapeutic agent daunorubicin (DNR). "
03/01/2012 - "The aim of this study was to investigate whether miR-181a could modulate the sensitivity of the leukemia drug-resistant cell line K562/A02 to the chemotherapeutic agent daunorubicin (DNR), and explore the mechanism of miR-181a on the DNR sensitivity of K562/A02 cells. "
|4.||Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
06/01/2001 - "We report the first randomized study assessing the efficacy and safety of daunorubicin (DNR) continuous infusion (CI) compared to the more conventional 30-min infusion (i.v.) in newly diagnosed adult acute lymphoblastic leukemia (ALL). "
06/01/2001 - "Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study."
08/01/2013 - "The dose intensity of daunorubicin (DNR) delivered during the induction period represented the major prognostic factor for the outcome of adult acute lymphoblastic leukemia (ALL). "
08/01/2013 - "Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia."
05/01/2010 - "Targeted delivery of daunorubicin to T-cell acute lymphoblastic leukemia by aptamer."
|5.||Acute Promyelocytic Leukemia
01/01/1981 - "Trial of daunomycin in acute promyelocytic leukemia of childhood: a Southwest Oncology Group Study."
01/01/1999 - "[Liposomal daunorubicin (daunosom) in the treatment of recurrent acute promyelocytic leukemia]."
09/01/1995 - "Effect of aggressive daunomycin therapy on survival in acute promyelocytic leukemia."
01/01/1988 - "High-dose daunorubicin (DNR) for induction and treatment of relapse in acute promyelocytic leukemia (APL): report of 17 cases."
01/01/1984 - "[Acute promyelocytic leukemia: retrospective study of 119 patients treated with daunorubicin]."
|5.||Idarubicin (4 Demethoxydaunorubicin)
|7.||Etoposide (VP 16)
|1.||Drug Therapy (Chemotherapy)
|3.||Combination Drug Therapy (Combination Chemotherapy)
|5.||Heterologous Transplantation (Xenotransplantation)